Verition Fund Management LLC

Q2 2025 13F-HR Detailed Holdings

Location
Greenwich, CT
Holdings as of
6/30/2025
Date filed
8/14/2025
Form type
13F-HR
Num holdings
3,603
Total value ($000)
$22,465,171
Net value change ($000)
+997,998 (4.6%)
New positions
520
Sold out positions
302
Turnover %
16.4%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q1 2025
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
LQD 342,274 30182.9%
QQQ 83,488 518.1%
SPY 80,753 65.1%
HYG 71,352 813.3%
CG 69,959 16383.8%
VCIT 55,971 NEW
CINF 48,708 397.5%
BRO 47,225 697.0%
FE 45,490 1505.8%
CHD 43,300 1195.5%
Top Reduces (Value $000, Stocks/ETFs)
IVV -1,168,739 -100.0%
AMZN -408,746 -83.9%
NVDA -324,481 -48.9%
MSFT -183,136 -66.7%
AEE -70,200 -98.7%
ED -54,884 -80.5%
ETR -49,085 -59.2%
PPL -42,230 -90.8%
Intra-Cellular Therapies, Inc. -39,830 -100.0%
SPOT -38,448 -97.5%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 5,089,058 (22.7% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None